Pulmonary tumor thrombotic microangiopathy is a rare form of pulmonary tumor embolism clinically indistinguishable from pulmonary thromboembolic disease. It is characterized by fibrocellular intimal proliferation of small pulmonary arteries and arterioles in patients with intraluminal tumor embolization. We report the case of a 67-year-old Caucasian woman who had been treated for breast cancer 5 years prior to presentation and had been free of recurrence on routine clinical surveillance. She was admitted for evaluation of three witnessed syncopal events accompanied by tachypnea and hypotension. Transthoracic echocardiography revealed severe right ventricular dilatation and severely reduced right ventricular function. Shortly after admission, the patient became acutely unresponsive and expired despite aggressive resuscitation measures. The proximate cause of death was a rupture of the right ventricular free wall and a large hemopericardium. Histopathology revealed extensive microscopic occlusions of small pulmonary arteries and arterioles by metastatic breast carcinoma with superimposed acute thrombi. Pulmonary tumor thrombotic microangiopathy should be included in the differential diagnosis of patients presenting with symptoms of pulmonary thromboembolism and a history of malignancy. <Learning objective: Pulmonary tumor thrombotic microangiopathy is a rare form of pulmonary tumor embolism clinically indistinguishable from pulmonary thromboembolic disease. It is characterized by fibrocellular intimal proliferation of small pulmonary arteries and arterioles in patients with intraluminal tumor embolization. The disease has a fulminant course and poor prognosis. It should be included in the differential diagnosis of patients presenting with symptoms of pulmonary thromboembolism and a history of malignancy.>
Introduction
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare form of pulmonary tumor embolism. It is typically associated with an underlying malignancy and is rarely diagnosed antemortem. We report an exceedingly rare case of PTTM causing right ventricular (RV) infarction, RV free wall rupture, and ensuing fatal hemopericardium.
Case report
A 67-year-old Caucasian woman presented with the acute onset of shortness of breath, chest pain, and three witnessed syncopal events the day prior to admission. Her past medical history was significant for breast cancer treated with resection and chemotherapy. She had been free of tumor recurrence at 5-year follow-up. Information regarding receptor status, type of chemotherapy, and adjuvant radiotherapy was not available at the time of admission. On presentation, she was tachypneic, hypotensive, and hypoxemic. The electrocardiogram showed sinus tachycardia, right axis deviation, and negative T-waves in the inferior and lateral leads. The electrocardiographic S 1 Q 3 pattern classically described in acute pulmonary embolism was not present. Cardiac troponin I was marginally elevated at 0.11 ng/mL (reference range, <0.04 ng/mL). and severely decreased RV function. Empiric treatment with intravenous heparin was initiated given the high clinical suspicion for acute pulmonary thromboembolism. A contrasted computerized tomography study of the chest and a ventilation-perfusion scan were obtained after initial hemodynamic stabilization. Both studies were unremarkable. A few hours later, the patient became acutely unresponsive and expired despite aggressive resuscitation measures, including mechanical ventilation, pharmacological and electrical cardioversion of atrial fibrillation with rapid ventricular response, vasopressor support, and large volume fluid resuscitation. Echocardiographic imaging was not available during cardiopulmonary resuscitation.
Autopsy identified a rupture of the anterior RV wall causing a large hemopericardium as the proximate cause of death (Fig. 1A) . The coronary arteries showed no occlusive or thrombotic lesions. Microscopic sections near the site of rupture demonstrated hypereosinophilic shrunken cardiomyocytes with a mild inflammatory infiltrate and intracellular edema, indicative of an acute myocardial infarction (Fig. 1B) . No large pulmonary emboli were identified on gross examination of the lungs. However, the pulmonary vasculature demonstrated extensive microscopic occlusion of small arteries and arterioles by metastatic breast carcinoma (confirmed by immunostaining) in association with acute fibrin thrombi. There were widespread chronic vascular changes including intimal and medial proliferation, fibrosis, and recanalization in association with carcinoma cells, suggesting a subacute accumulation of tumor emboli prior to the current presentation ( Fig. 1C and D) . A reservoir of carcinoma was identified in the bone marrow and in several peri-aortic lymph nodes completely effaced by tumor cells. Discussion PTTM is a rare clinicopathological form of pulmonary tumor embolism with fulminant clinical course, no effective treatment, and poor prognosis [1] [2] [3] . It is clinically indistinguishable from pulmonary thromboembolism and is usually diagnosed postmortem. It is found in 0.9-3.3% of autopsies of patients with adenocarcinomas of the breast, stomach, liver, colon, and lung. Histologically, it is characterized by concentric fibrocellular intimal and medial proliferation of small pulmonary arteries and arterioles with associated thrombus formation. The proliferative process of smooth muscle cells and fibroblasts is triggered by the activation of the coagulation cascade in the pulmonary vasculature and the release of inflammatory mediators and growth factors, including endothelial growth factor, platelet-derived growth factor, and pleiotropic cytokines [4] . Clinically, acute or sub-acute cor pulmonale, sudden cardiovascular collapse, pulmonary hypertension, and increased pulmonary vascular resistance are manifestations of the disease.
RV infarction is known to occur in the acute phase of large pulmonary thromboembolism in the absence of obstructive coronary lesion or thrombosis [5] . Pathophysiologically, low cardiac output, hypoxemia, systemic hypotension, and increased RV afterload result in decreased coronary perfusion pressure and increased myocardial oxygen consumption. These factors likely led to RV subendocardial ischemia and infarction with subsequent rupture of the RV free wall despite the lack of significant obstructive coronary lesions in the presented case. We also carefully considered whether cardiopulmonary resuscitation might have contributed to RV rupture and hemopericardium. The sternal plate was carefully examined at autopsy. Particular attention was focused on the integrity of the sternum and articulating ribs for signs of fracture and internal organ damage. The sternal plate was found to be intact and free of fractures. Furthermore, there was no laceration of the pericardium or contusion of any other cardiac structure or of the left lung parenchyma; there was no hemothorax, leading us to believe that the extensive burden of PTTM resulted in RV infarction and rupture of the RV free wall with ensuing hemopericardium.
Conclusions
PTTM is an under-recognized clinical entity that should be considered in patients with a history of malignancy and symptoms suggestive of pulmonary embolism, provided that pulmonary thromboembolic disease has been excluded. The diagnosis of PTTM has implications for treatment options, prognosis, and outcome.
